Patents by Inventor M. K. Bhan

M. K. Bhan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cloning and expression of outer membrane protein C of salmonella typhi Ty2 and conjugation of the purified insoluble protein to VI-polysaccharide for use as a vaccine for typhoid fever
    Publication number: 20070197777
    Abstract: The invention relates to a novel carrier protein for use as a vaccine comprising the outer membrane protein C (OmpC) of Salmonella typhi Ty2 for conjugation with VI polysaccharide.
    Type: Application
    Filed: April 23, 2007
    Publication date: August 23, 2007
    Inventors: B. L. Jailkhani, M. K. Bhan, R. Kumar, S. Sengupta, Shabirul Haque
  • Cloning and expression of outer membrane protein C of Salmonella typhi Ty2 and conjugation of the purified insoluble protein to VI-polysaccharide for use as a vaccine for typhoid fever
    Publication number: 20070082015
    Abstract: The invention relates to a novel carrier protein for use as a vaccine comprising the outer membrane protein C (OmpC) of Salmonella typhi Ty2 for conjugation with VI polysaccharide.
    Type: Application
    Filed: October 7, 2005
    Publication date: April 12, 2007
    Applicants: ALL INDIA INSTITUTE OF MEDICAL SCIENCES, DEPARTMENT OF BIO TECHNOLOGY
    Inventors: B. L. Jailkhani, M. K. Bhan, R. Kumar, S. Sengupta, Shabirul Haque
  • Rotavirus strain G9P11
    Patent number: 5773009
    Abstract: Provided is an isolated rotavirus of the strain G9P11, an isolated nucleic acid encoding the rotavirus of strain G9P11 and a purified antigen specific for the rotavirus. An isolated nucleic acid encoding the antigen of the rotavirus is also provided, as is an isolated nucleic acid that selectively hybridizes under high stringency conditions with the nucleic acid encoding te virus. A purified antibody which selectively binds the virus of strain G9P11 is provided. The G9P11 rotavirus in a pharmaceutically acceptable carrier for administration in an immunization protocol is provided. Also provided is an isolated rotavirus of strain G9P11, wherein the G9 gene is substituted. Further provided is an isolated rotavirus of strain G9P11, wherein the P11 gene is substituted.
    Type: Grant
    Filed: February 19, 1997
    Date of Patent: June 30, 1998
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Roger I. Glass, John R. Gentsch, M. K. Bhan, Bimal K. Das